Contact hours available until 8/31/2014

Requirements for Successful Completion: Complete the learning activity in its entirety and completethe online CNE evaluation.

Faculty; Planners and Authors Conflict of Interest Disclosure:The author; editor; and education director reported no actual or potential conflict of interest in relation to thiscontinuing nursing education article.

Urologic Nursing Editorial Board Statements of Disclosure:Susanne A. Quallich; ANP-BC; NP-C; CUNP; disclosed that she is on the Consultants' Bureau for Coloplast. All other Urologic Nursing Editorial Board members reported no actual or potential conflict of interest in relation to this continuing nursing education activity.

Commercial Support and Sponsorship: No commercial support or sponsorship declared.

Non-Endorsement of Products: Accreditation of activities for contact hours does not imply approval or endorsement of any product; advertising; or educational content by SUNA or the American Nurses Credentialing Center's Commission on Accreditation.

Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Accreditation status does not imply endorsement by the provider or ANCC of any commercial product. SUNA is a provider approved by the California Board of Registered Nursing; provider number; CEP 5556.

Objectives:

Explain the likely causes for the rise in incidence of renal cell carcinoma in the United States.
Describe the classification; grading; and staging systems of renal cell carcinoma.
Discuss treatment modalities for patients with renal cell carcinoma.

Chintan Patel

Appearances